About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 1378 record(s)
Req # A-2019-001524
The clinical overview, clinical summary of efficacy and clinical summary of safety information submitted to Health Canada as part of the supplementary new drug submission (SNDS) for XELJANZ.Organization: Health Canada
December 2021
Req # A-2019-001765
All documents pertaining to project or program funding agreements and subsequent deliverables for agreement 1920-HQ-000053 (July 9, 2019 - June 30, 2022) Details # 271-2019-2020-Q2-00011 $790,500.00 for Association for Action on Smoking and Health.Organization: Health Canada
December 2021
Req # A-2020-000312
All Task & Solutions Professional Services (TSPS) and Task Based Informatics Professional Services (TBIPS) Supply Arrangement (SA) contracts and Standing Offer (SO) callups issued in the National Capital Region for the months of October 2019, November 2019, December 2019, January 2020, February 2020 & March 2020.Organization: Health Canada
December 2021
Req # A-2020-000769
The name of the manufacturer of the LAP-BAND Adjustable Gastric Banding (LAGB) System (License No. 12197) medical device as of the device's first issuance date September 20, 1999.Organization: Health Canada
December 2021
Req # A-2020-000770
A copy of the Medical Device License of the LAP-BAND Adjustable Gastric Banding (LAGB) System (License No. 12197) medical device as of the device's first issuance date September 20, 1999.Organization: Health Canada
December 2021
Req # A-2020-000864
The information submitted by the Canadian licensed producer HEXO in regard to a line of cannabis extracts they manufacture under the company name Truss Beverage Co. The line of cannabis for the line of Veryvell cannabis extract drops. All information submitted by the licensed producer in relation to the notice of new cannabis product (NNCP) that was submitted for the Veryvell line of cannabis products in relation to: Cannabis product form, ingredients in the cannabis product, sensory attributes and anything else that significantly distinguishes the product or makes it novel.Organization: Health Canada
December 2021
Req # A-2020-001360
All documents from March 1, 2020 to May 2, 2020 concerning the decision to hire an external contractor to lead the implementation of Canada's COVID-19 testing strategy.Organization: Health Canada
December 2021
Req # A-2021-000118
All documents up to May 2nd, 2021 between Novavax Inc and Health Canada with regard to the Novavax COVID-19 vaccine, also known as NVX-CoV2373, also known as SARS-CoV-2 rS (recombinant spike) protein nanoparticle vaccine with Matrix-M1 adjuvant.Organization: Health Canada
December 2021
Req # A-2021-000635
Documents that address Health Canada protocols for interception or seizure of Lysergic acid diethylamide (LSD), including, but not limited to, agency protocols for: training related to the seizure of LSD, search, notification, testing, storage, destruction, return or forfeiture. Timeline: July 1 2018 to July 19 2021.Organization: Health Canada
December 2021
Req # A-2021-000637
Documents that address Health Canada protocols for interception or seizure of 3,4-Methylenedioxymethamphetamine (MDMA), including, but not limited to, agency protocols for: training related to the seizure of MDMA, search, notification, testing, storage, destruction, return or forfeiture. Timeline: July 1 2018 to July 19 2021.Organization: Health Canada
December 2021